Advances in emerging drugs for osteosarcoma
New treatment approaches and drugs are therefore highly warranted to improve prognosis.
This review focuses on the therapeutic approaches that are under development or clinical evaluation in OS.
The continued development of novel therapeutic agents and strategies for osteosarcoma is needed
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Related signals
- Potential proteins identified to target in osteosarcoma treatment
- Future Directions in the Treatment of Osteosarcoma
- Is There a Role for Mifamurtide in Nonmetastatic High‑Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS‑2) and Spanish Sarcoma Group (GEIS‑33) Trials
- The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights
- Amputation and Chemotherapy for Osteosarcoma